Metformin prevents non-alcoholic fatty liver disease in rats : role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes

OBJECTIVE: To investigate the potential preventive effects of metformin on non-alcoholic fatty liver disease (NAFLD) and roles of phospholipase A2/lysophosphatidylcholine pathway in hepatocyte lipoapoptosis in a rat NAFLD model induced by high-fat diet

Détails bibliographiques
Publié dans:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 49(2011), 2 vom: 23. Feb., Seite 139-45
Auteur principal: Huang, Yao (Auteur)
Autres auteurs: Fu, Jun-fen, Shi, Hong-bo, Liu, Li-rui
Format: Article
Langue:Chinese
Publié: 2011
Accès à la collection:Zhonghua er ke za zhi = Chinese journal of pediatrics
Sujets:English Abstract Journal Article Research Support, Non-U.S. Gov't Lysophosphatidylcholines Metformin 9100L32L2N Phospholipases A2 EC 3.1.1.4